OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/305% below fair value
$31.74−0.77 (-2.37%)
Close on Nov 20, 2026Market cap $828.75MP/E –Yield –
OrthoPediatrics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
OrthoPediatrics's operating income for the twelve months ending Sep 30, 2026 was -$24.80M. For fiscal 2025 it was -$39.24M. The highest annual figure on record is -$6.13M in fiscal 2016.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$39.24M | – |
| FY2024 | Dec 31, 2024 | -$35.01M | – |
| FY2023 | Dec 31, 2023 | -$26.75M | – |
| FY2022 | Dec 31, 2022 | -$25.40M | – |
| FY2021 | Dec 31, 2021 | -$18.02M | – |
| FY2020 | Dec 31, 2020 | -$26.76M | – |
| FY2019 | Dec 31, 2019 | -$9.08M | – |
| FY2018 | Dec 31, 2018 | -$9.55M | – |
| FY2017 | Dec 31, 2017 | -$6.47M | – |
| FY2016 | Dec 31, 2016 | -$6.13M | – |
| FY2015 | Dec 31, 2015 | -$6.59M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$4.23M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.17M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.66M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.67M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.72M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.07M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.51M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.96M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.74M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.56M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.64M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.02M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.03M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.79M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.72M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.87M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.40M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$754.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$677.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$837.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.25M | – |
See a number that looks wrong?